Migrant health series: Epidemiology of HIV and AIDS in migrant communities and ethnic minorities in EU/EEA countries
This document describes the burden of HIV infection in migrant populations and its contribution to the epidemiology of HIV in the period 1999–2006. Data from ECDC/former EuroHIV were used, globally and for each EU/EEA country, and absolute numbers and percentages of cases of AIDS and HIV were examined by geographical origin and year, stratified by sex and transmission categories.
This report is part of the ECDC Report on migration and infectious diseases in the EU, a series of documents presenting data analysis, evidence summary, interpretation and guidance on interventions in the field of migration and selected infectious diseases.
Overview of the implementation of COVID-19 vaccination strategies and deployment plans in the EU/EEA
23 Sep 2021 - This report provides an updated overview of the progress of national COVID-19 vaccination strategies in EU/EEA countries, including updates on: vaccine uptake overall and by target group; current vaccination phases and priority groups, as well as any adjustments made to priority groups during the rollout; vaccination strategies and policies in place; and the use of vaccination certificates and challenges countries face with the rollout and good practices to mitigate these challenges.
HIV Continuum of care: Monitoring implementation of the Dublin Declaration on partnership to fight HIV/AIDS in Europe and Central Asia (2020 progress report)
16 Aug 2021 - In 2020, using data from countries able to provide at least two consecutive stages of the continuum, the overall performance of the European and Central Asian region against the global 90-90-90 targets is 82% of all PLHIV with HIV diagnosed, 67% of those diagnosed with HIV on treatment and 90% of those on treatment virally suppressed. More progress is needed to meet the substantive target of 73% of all PLHIV being virally suppressed, with performance for the overall region at 50% (based on the countries that submitted data for all four stages of the continuum).
Partial COVID-19 vaccination, vaccination following SARS-CoV-2 infection and heterologous vaccination schedule: summary of evidence
22 Jul 2021 - This document provides a review of evidence on three topics of interest (effectiveness of partial vaccination, immunogenicity and effectiveness of vaccination for previously infected individuals and safety and immunogenicity of heterologous schedules) to inform ongoing decision-making in relation to national vaccination policies and strategies in the European Union and European Economic Area (EU/EEA) countries.